Reduction of aluminum ion neurotoxicity through a small peptide application - NAP treatment of Alzheimer's disease

J Food Drug Anal. 2019 Apr;27(2):551-564. doi: 10.1016/j.jfda.2018.11.009. Epub 2019 Jan 12.

Abstract

Alzheimer's disease (AD) is the most common cause of dementia in late life. It is difficult to precisely diagnose AD at early stages, making biomarker search essential for further developments. The objective of this study was to identify protein biomarkers associated with aluminum ions toxicity (AD-like toxicity) in a human neuroblastoma cell model, SH-SY5Y and assess potential prevention by NAP (NAPVSIPQ). Complete proteomic techniques were implemented. Four proteins were identified as up-regulated with aluminum ion treatment, CBP80/20-dependent translation initiation factor (CTIF), Early endosome antigen 1 (EEA1), Leucine-rich repeat neuronal protein 4 (LRRN4) and Phosphatidylinositol 3-kinase regulatory subunit beta (PI3KR2). Of these four proteins, EEA1 and PI3KR2 were down-regulated after NAP-induced neuroprotective activity in neuroblastoma cells. Thus, aluminum ions may increase the risk for neurotoxicity in AD, and the use of NAP is suggested as a treatment to provide additional protection against the effects of aluminum ions, via EEA1 and PI3KR2, associated with sorting and processing of the AD amyloid precursor protein (APP) through the endosomal system.

Keywords: Activity-dependent neuroprotective protein (ADNP); Aluminum ion; Alzheimer's disease (AD); NAP; Proteomics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aluminum / toxicity
  • Alzheimer Disease / chemically induced
  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / pathology
  • Cell Proliferation / drug effects
  • Dose-Response Relationship, Drug
  • Humans
  • Ions / toxicity
  • Neuroprotective Agents / chemistry
  • Neuroprotective Agents / pharmacology*
  • Neurotoxins / toxicity
  • Oxidation-Reduction
  • Peptide Fragments / chemistry
  • Peptide Fragments / pharmacology*
  • Small Molecule Libraries / chemistry
  • Small Molecule Libraries / pharmacology*
  • Structure-Activity Relationship
  • Tumor Cells, Cultured

Substances

  • Ions
  • Neuroprotective Agents
  • Neurotoxins
  • Peptide Fragments
  • Small Molecule Libraries
  • Aluminum

Grants and funding

This work was supported by Research Grants: MOST 107-2320-B-037-003 from the Ministry of Science and Technology; KMU-TP105E12, 105KMUOR05 and KMU-O104003 (Aim for the Top 500 Universities Grant) from Kaohsiung Medical University; 105-CCH-KMU-005 from CCH-KMU Research Project; NSY-SUKMU106-P011 from NSYSU-KMU Research Project; AS-KPQ-105-TPP Taiwan Protein Project and the Research Center for Environmental Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan from The Featured Areas Research Center Program within the framework of the Higher Education Sprout